Fluvastatin for reduction of cardiovascular risk in patients with moderate to severe renal insufficiency.
Haynes
Richard
R
Clinical Trial Service Unit, University of Oxford, Oxford, UK. richard.haynes@ctsu.ox.ac.uk
Armitage
Jane
J